• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Introduction to Tert-butyl 2-(1-isocyanatocyclopropyl)-5,5-dimethylpiperidine-1-carboxylate (CAS No. 2649068-72-2)

Tert-butyl 2-(1-isocyanatocyclopropyl)-5,5-dimethylpiperidine-1-carboxylate, identified by its Chemical Abstracts Service (CAS) number 2649068-72-2, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to a class of molecules characterized by its unique structural features, which include a tert-butyl group, a cyclopropyl moiety, and an isocyanate functional group. These structural elements contribute to its distinctive chemical properties and potential applications in the development of novel therapeutic agents.

The tert-butyl group is a well-known sterically hindered alkyl group that often enhances the metabolic stability of pharmaceutical compounds. Its presence in this molecule suggests that it may be designed to resist rapid degradation in biological systems, which is a critical factor in drug design. The cyclopropyl ring is another notable feature, as it introduces a rigid three-membered carbon cycle that can influence the conformation and reactivity of the molecule. This structural motif has been explored in various drug candidates due to its ability to interact with biological targets in specific ways.

The most distinctive feature of Tert-butyl 2-(1-isocyanatocyclopropyl)-5,5-dimethylpiperidine-1-carboxylate is the presence of an isocyanate functional group. Isocyanates are highly reactive species that can participate in a variety of chemical transformations, including the formation of ureas and carbamates. These reactions are particularly relevant in pharmaceutical chemistry, where isocyanates have been used to construct complex molecular frameworks. The incorporation of an isocyanate group into this compound suggests potential applications in the synthesis of bioactive molecules, such as protease inhibitors or kinase inhibitors, which are critical targets in modern drug discovery.

Recent advancements in medicinal chemistry have highlighted the importance of structural diversity in drug design. Compounds like Tert-butyl 2-(1-isocyanatocyclopropyl)-5,5-dimethylpiperidine-1-carboxylate represent a growing interest in exploring novel scaffolds that can offer unique binding interactions with biological targets. The combination of a tert-butyl group, a cyclopropyl moiety, and an isocyanate functional group makes this compound a promising candidate for further investigation.

In the context of current research, there has been increasing focus on the development of small-molecule inhibitors that can modulate enzyme activity. Enzymes such as kinases and proteases play pivotal roles in numerous biological pathways, and their inhibition is often a key strategy in therapeutic intervention. The reactivity of the isocyanate group in Tert-butyl 2-(1-isocyanatocyclopropyl)-5,5-dimethylpiperidine-1-carboxylate provides a versatile tool for constructing inhibitors that can target these enzymes. For instance, the isocyanate functionality can be used to form covalent bonds with specific amino acid residues in the active site of an enzyme, leading to potent and selective inhibition.

Additionally, the tert-butyl group and cyclopropyl ring contribute to the overall shape and electronic properties of the molecule, which can be fine-tuned to optimize binding affinity and selectivity. These structural features allow for precise interactions with biological targets, minimizing off-target effects and enhancing therapeutic efficacy. The rigid nature of the cyclopropyl ring, combined with the steric bulk provided by the tert-butyl group, can help stabilize key interactions within the binding pocket of an enzyme or receptor.

One area where this compound shows particular promise is in the development of antiviral agents. Viruses rely on host enzymes for replication, making them susceptible to inhibition by small-molecule drugs. The unique structural features of Tert-butyl 2-(1-isocyanatocyclopropyl)-5,5-dimethylpiperidine-1-carboxylate could be exploited to design inhibitors targeting viral proteases or polymerases. The reactivity of the isocyanate group allows for covalent bond formation with critical residues in these enzymes, potentially leading to highly effective antiviral treatments.

Another emerging application is in the field of immunomodulation. Immune responses are tightly regulated by various enzymes and signaling pathways, and modulating these processes can have therapeutic benefits. For example, compounds targeting immune checkpoint proteins have revolutionized cancer immunotherapy. The structural motifs present in Tert-butyl 2-(1-isocyanatocyclopropyl)-5,5-dimethylpiperidine-1-carboxylate could be adapted to develop inhibitors that modulate immune cell function, offering new avenues for treating autoimmune diseases or enhancing anti-tumor responses.

The synthesis and further characterization of this compound are ongoing areas of research. Advances in synthetic methodologies have enabled chemists to construct increasingly complex molecular architectures with precision. Techniques such as transition-metal-catalyzed reactions and organometallic chemistry have been instrumental in developing novel derivatives of compounds like this one. These synthetic strategies allow for fine-tuning of key functional groups while maintaining overall structural integrity.

In conclusion,Tert-butyl 2-(1-isocyanatocyclopropyl)-5,5-dimethylpiperidine-1-carboxyllate (CAS No. 2649068-72-2) represents a promising candidate for further exploration in pharmaceutical research. Its unique structural features—comprising a tert-butyl group, a cyclopropyl moiety, and an isocyanate functional group—offer versatile opportunities for designing bioactive molecules with potential applications across multiple therapeutic areas. As research continues to uncover new mechanisms underlying disease pathogenesis,this compound may play an important role in developing innovative treatments for various medical conditions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)